Previous Article | Next Article ![]()
Journal of Bacteriology, May 2003, p. 3218-3222, Vol. 185, No. 10
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.10.3218-3222.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Division of Biological Sciences, University of California at San Diego, La Jolla, California 92093-0116
Received 8 January 2003/ Accepted 3 March 2003
|
|
|---|
|
|
|---|
Very few of the proteins of the APC superfamily are functionally characterized, and 2 of the 10 previously defined families within the APC superfamily do not include even one functionally characterized member. We have (i) cloned, (ii) overexpressed, and (iii) knocked out the gene encoding a member of a novel family within the APC superfamily from B. subtilis, yveA. We show that this protein (i) catalyzes uptake of L-aspartate, (ii) mediates sensitivity to aspartate hydroxamate, (iii) probably exhibits specificity for L-aspartate, L-glutamate, L-aspartic hydroxamate, and possibly L-asparagine and L-glutamine, (iv) allows enhanced growth with L-aspartate as the sole nitrogen source, and (v) exhibits maximal activity after growth in the presence of L-aspartate. The results show that YveA is the principal aspartate transporter in B. subtilis.
The B. subtilis yveA gene was amplified by PCR using the Pfx platinum polymerase and B. subtilis chromosomal DNA as the template. To overexpress yveA in B. subtilis, the XbaI-PstI-amplified fragment was fused to the B. subtilis promoter Pspac present on plasmid pAG58 (3). The yveA gene combined with Pspac was further subcloned (as an EcoRI-PstI DNA fragment) into the E. coli-B. subtilis shuttle vector pMK4, which encodes a chloramphenicol resistance marker (9). The Pspac promoter is known to be a weak isopropyl-ß-D-thiogalactopyranoside-inducible promoter, and pMK4 is a low-copy-number plasmid (3, 9). These facts are in agreement with the results reported below (see Fig. 2).
![]() View larger version (17K): [in a new window] |
FIG. 2. Time courses for the uptake of L-[14C]aspartate (A) and L-[14C]glutamate (B) into B. subtilis cells. M168 (wild type) ( ), knockout mutant (M168 yveA) (), M168 cells expressing the plasmid-encoded yveA gene (M168 with Pspac-yveA) ( ), and the chromosomal yveA knockout mutant expressing the yveA-bearing plasmid ( ). Cells were grown for 24 h at 37°C in minimal SM medium with 0.1% D-glucose and 10 mM aspartate. Cells were harvested in the exponential growth phase, washed twice, and resuspended in 50 mM Tris-maleate-5 mM MgCl2 (TM buffer) (pH 7.0) to an optical density of 0.1. The energy source (8 mM glucose) and either L-aspartate or L-glutamate (20 µM; 5 µCi/µmol) were added to a temperature-equilibrated 1-ml cell suspension at 0 min. Transport assays were conducted at 37°C. Samples (0.1 ml) were removed at appropriate times as shown, filtered (25-mm membrane filters; 45-µm pore size), washed three times with cold TM buffer, dried, and then transferred to vials containing 10 ml of scintillation fluid for determination of radioactivity. Values reported represent the averages of two independent assays.
|
cells and transformed in B. subtilis M168 (wild-type) cells by natural competence. To construct the knockout mutant, the yveA gene was amplified by PCR and inserted into the cloning vector pPCR-Script Amp in the SrfI site. An internal fragment (500 bp) of the cloned gene was deleted by cutting with MunI. The 4-kb fragment of the cut plasmid was recovered from the gel, purified, and blunted with the Klenow enzyme. The fragment was further dephosphorylated and ligated to the kanamycin gene from pER82 (kindly provided by K. Pogliano, University of California at San Diego). The presence of the inserted gene was confirmed by PCR. |
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
21 h. Growth enhancement relative to that of the wild-type strain (both the extent of growth and apparent growth rate) (dt =
10.4 h) was observed for the yveA plasmid expression strain (dt =
7.3 h). Similar behavior was observed when 0.1% Casamino Acids was included in the growth medium, although the differences were less pronounced (data not shown). These results suggested that YveA mediates uptake of L-aspartate but that it is not the sole transporter providing this function.
![]() View larger version (14K): [in a new window] |
FIG. 1. Growth curves for B. subtilis strain M168 (wild type) ( ), a yveA knockout mutant (M168 yveA) (), and M168 cells overexpressing the yveA gene (M168 + Pspac-yveA) ( ). Cells were grown for 48 h at 37°C in minimal SM medium (80 mM K2HPO4, 44 mM KH2PO4, 3.4 mM trisodium citrate, 2 mM MgSO4, 6.7 mM KCl, 0.5 mM CaCl2, 5 µM MnCl2, 0.5 µM FeSO4) with 0.1% D-glucose and 10 mM aspartate. The optical density was measured at 600 nm.
|
Figure 2 shows the uptake of L-[14C]aspartate (Fig. 2A) and L-[14C]glutamate (Fig. 2B), both at a concentration of 20 µM, as a function of time for the wild type and yveA knockout mutant with and without the overexpressing plasmid. The knockout mutant barely took up L-[14C]aspartate, while the overproducing strain took up more than the wild type. The same was observed for L-[14C]glutamate uptake, although the background activity of the yveA knockout mutant was substantially higher (over twofold higher than the wild-type aspartate uptake rate), and the increase, due to the reintroduction of the yveA gene, was less. The L-[14C]aspartate incorporation rate by the wild-type strain showed saturation at 100 µM aspartate, with a Vmax of 1.1 ± 0.1 nmol min-1 mg-1 (dry weight) and an apparent Km of 25 ± 3 µM.
Using the same conditions described in Table 2, the energetics of L-aspartate uptake were studied. Carbonyl cyanide m-chlorophenyl hydrazone and carbonyl cyanide 4-trifluoromethoxyphenylhydrazone, both at 5 µM, blocked uptake >95%. Substitution of Na+ for K+ in the uptake buffer did not result in decreased uptake (±5%). It is therefore likely that L-aspartate uptake is a proton-motive forcerather than a sodium-motive force-driven processand that the mechanism of transport is amino acid-H+ symport.
|
View this table: [in a new window] |
TABLE 2. Inhibition of the initial L-[14C]aspartate uptake rate by the L- and D-isomers of several amino acids
|
45%), showing that substrate recognition is not strictly stereospecific. These results, together with the growth and aspartic hydroxamate inhibition results, suggest that YveA transports amino acids with relative affinities in the order of aspartate hydroxamate > L-aspartate > L-glutamate, but it recognizes a much broader range of amino acids. Uptake of several L-amino acids was measured in the wild-type and yveA mutant strains. The cells were grown with either aspartate or proline as the sole source of nitrogen. Table 3 shows that the yveA mutant strain grown with aspartate took up less aspartate and glutamate but more asparagine, glutamine, alanine, and serine compared to the wild-type control strain. These results indicate that poor growth observed in the yveA mutant strain might have caused increased activity of other permeases. This suggestion was substantiated by the fact that proline-grown mutant cells showed decreased uptake of aspartate and glutamate but a lesser differential for most of the other amino acids when compared with the wild-type strain. The large reproducible differential observed for L-asparagine and L-glutamine is unexplained.
|
View this table: [in a new window] |
TABLE 3. Uptake of14C-labeled L-amino acids in cells grown in SM medium with either aspartate or proline (10 mM) as the sole nitrogen sourcea
|
|
View this table: [in a new window] |
TABLE 4. ß-Galactosidase activity of a yveA-lacZ translational fusion after growth with different amino acids as the sole nitrogen sourcea
|
In this communication we have demonstrated that YveA is the primary L-aspartate transporter of B. subtilis following growth under standard laboratory conditions. Based on the inhibition studies with aspartate hydroxamate, it must also transport this aspartate analogue. The system also transports L-glutamate but with lower affinity and efficiency. The main glutamate transporter, GltP (P39817), has been described previously (2, 10).
YveA is the first member of a new family within the APC superfamily to be characterized functionally. In an earlier communication, 10 families were described for the APC superfamily (4). Figure 3 shows a phylogenetic tree for this superfamily, including representative members of the 10 previously defined families (families 1 to 10 in Fig. 3). As can be seen in the figure, members of these 10 families cluster in accordance with the expectation based on the results of Jack et al. (4). However, the tree shown in Fig. 3 defines a new family that we have called the aspartate/glutamate transporter (AGT) family (family 11; TC 2.A.3.11). YveA of B. subtilis is the only characterized member of the AGT family, and it is therefore the prototype for this family. In contrast to all other prokaryotic members of the APC superfamily (4), all of the members of this family exhibit 14 rather than 12 putative transmembrane segments (TMSs). The two extra TMSs are found C-terminal to the 12 TMSs that are common to other members of the superfamily. It should be noted that YveA was included as a highly divergent member of the ABT family by Jack et al. (4). The expansion of this family due to the increased sequence data now available allows segregation of the previously specified ABT family into two families of different topological protein types (Fig. 3).
![]() View larger version (40K): [in a new window] |
FIG. 3. Phylogenetic tree for representative members of the APC superfamily. The 10 previously identified families (labeled 1 to 10 in parentheses following the family abbreviation) were as described by Jack et al. (4). Abbreviations of the proteins in these families were as defined therein. The new family to which YveA belongs is the AGT family (TC 2.A.3.11). The tree was derived from a multiple alignment obtained using the ClustalX program as detailed previously (4). Members of the AGT family include YveA Bsu (B. subtilis gi1945680); YbeC Bsu (B. subtilis gi2632498); Orf1 Sto (Sulfolobus tokodaii gi15922067); Orf1 Tvo (Thermoplasma volcanium gi13542093); and Orf1 Tac (Thermoplasma acidophilum gi16081310).
|
G. Lorca and B. Winnen contributed equally to the work reported.
This work was supported by NIH grant GM64368. G.L.L. was supported by a fellowship from the Pew Latin American Program in the Biomedical Sciences.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»